Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bayer Has Schering AG Green Light

This article was originally published in The Pink Sheet Daily

Executive Summary

Bayer has met the quota for percentage of shares needed to acquire Schering AG, the firm said June 19

You may also be interested in...



Schering Integration On Track, Bayer CEO Says

Schering AG stockholders to vote Sept. 13 on a domination and profit and loss transfer agreement with Bayer subsidiary Dritte BV.

Schering Integration On Track, Bayer CEO Says

Schering AG stockholders to vote Sept. 13 on a domination and profit and loss transfer agreement with Bayer subsidiary Dritte BV.

Schering AG To Continue Leukine Development In Wake Of Disappointing Phase III Trial

Bayer offer to purchase Schering AG stands despite trial setbacks and expansion of Ultravist recall.

Related Content

Topics

UsernamePublicRestriction

Register

ID1131516

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel